Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas

被引:9
|
作者
Deng, Xiangyang [1 ]
Yang, Xionggang [2 ]
Yang, Chunlei [1 ]
Chen, Kezhu [1 ]
Ren, Junwei [1 ]
Zeng, Jun [1 ]
Zhang, Quan [1 ]
Li, Tianwen [1 ]
Tang, Qisheng [1 ]
Zhu, Jianhong [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Inst Brain Sci, Inst Neurosurg,Dept Neurosurg,Shanghai Med Coll,Na, Shanghai, Peoples R China
[2] Fudan Univ, Dept Orthopaed Surg, Huashan Hosp, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
socioeconomic deprivation; primary central nervous system lymphoma; SEER; overall survival (OS); cancer-specific survival; PRIMARY CNS LYMPHOMA; ELDERLY-PATIENTS; UNITED-STATES; NEIGHBORHOOD; RACE/ETHNICITY; DISADVANTAGE; DISPARITIES; DIAGNOSIS;
D O I
10.3389/fonc.2022.929585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo our knowledge, the impact of area-level socioeconomic status (SES) has not yet been described in primary central nervous system lymphomas (PCNSLs). Current study sought to explore the association of socioeconomic deprivation, measured using the Area Deprivation Index (ADI), with PCNSL outcomes. MethodsThe Surveillance, Epidemiology, and End Results (SEER) database was used to identify PCNSL patients diagnosed between 2006 and 2015 for our analyses. The impact of ADI on overall survival (OS) and cancer-specific survival (CSS) were investigated. Survival analyses were conducted using Kaplan-Meier method with log-rank tests. The Inverse Probability Weighting (IPW) analysis and multivariate cox proportional hazards regression analysis were employed to make covariate adjustments. Multiple mediation analysis (MMA) was performed to estimate the mediating effects. ResultsA total of 3159 PCNSL patients classified into low and high ADI subgroups according to the median ADI score were studied. The Kaplan-Meier analyses showed that low ADI was significantly associated with higher OS rates (HR 1.15, 95%CI 1.06-1.26, P<0.01) and CSS rates (HR 1.15, 95%CI 1.05-1.27, P<0.01). Similar results were observed in analyses adjusted via IPW and multivariate cox methods. Subgroup analyses revealed that ADI could remain a prognostic indictor among different subsets. MMA revealed that several factors including chemotherapy and HIV status making up about 40% of the overall effect, mediated PCNSL survival disparities related to the ADI. Finally, multivariable logistic regression analysis showed that ADI as well as several other factors were independently related to receipt of chemotherapy. ConclusionsOur study highlights the role of area-level SES in prognosis of PCNSLs. And several factors including chemotherapy and HIV status of PCNSL patents contributed to the CSS disparities between ADI subgroups were uncovered by MMA. Such relationships would highlight the importance of policies development to enhance healthcare delivery and promote awareness of HIV prevention and treatment in low-resource neighborhoods.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Ibrutinib Therapy in Relapsed/Refractory Primary Central Nervous System Lymphomas
    Guven, Serkan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S458 - S459
  • [42] Craniotomy and Survival for Primary Central Nervous System Lymphoma
    Rae, Ali I.
    Mehta, Amol
    Cloney, Michael
    Kinslow, Connor J.
    Wang, Tony J. C.
    Bhagat, Govind
    Canoll, Peter D.
    Zanazzi, George J.
    Sisti, Michael B.
    Sheth, Sameer A.
    Connolly, E. Sander
    McKhann, Guy M.
    Bruce, Jeffrey N.
    Iwamoto, Fabio M.
    Sonabend, Adam M.
    NEUROSURGERY, 2019, 84 (04) : 935 - 943
  • [43] Updates on Primary Central Nervous System Lymphoma
    Schaff, Lauren R.
    Grommes, Christian
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [44] Updates of primary central nervous system lymphoma
    Wu, Jiaying
    Zhou, Delian
    Zhu, Xiaojian
    Zhang, Yicheng
    Xiao, Yi
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [45] Rare central nervous system lymphomas
    Kaji, Furqaan Ahmed
    Martinez-Calle, Nicolas
    Sovani, Vishakha
    Fox, Christopher Paul
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (06) : 662 - 678
  • [46] Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study
    Tang, Dongsheng
    Chen, Yue
    Shi, Yuye
    Tao, Hong
    Tao, Shandong
    Zhang, Quan'e
    Ding, Banghe
    He, Zhengmei
    Yu, Liang
    Wang, Chunling
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact
    Blasel, Stella
    Vorwerk, Rieke
    Kiyose, Makoto
    Mittelbronn, Michel
    Brunnberg, Uta
    Ackermann, Hanns
    Voss, Martin
    Harter, Patrick N.
    Hattingen, Elke
    JOURNAL OF NEUROLOGY, 2018, 265 (03) : 647 - 658
  • [48] Progress in central nervous system lymphomas
    Wang, Chia-Ching
    Carnevale, Julia
    Rubenstein, James L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (03) : 311 - 325
  • [49] The impact of tumor resection on survival and functional outcomes for patients with primary central nervous system lymphoma
    Nien, Ju-En
    Chuang, Chi-Cheng
    Hsu, Peng-Wei
    Huang, Yin-Cheng
    Tsai, Hong-Chieh
    Chen, Pin-Yuan
    Lee, Cheng-Chi
    Lu, Yu-Jen
    Lin, Ya-Jui
    Wei, Kuo-Chen
    Chen, Ko-Ting
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 246
  • [50] Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors
    Puthenpura, Vidya
    Canavan, Maureen E.
    Poynter, Jenny N.
    Roth, Michael
    Pashankar, Farzana D.
    Jones, Beth A.
    Marks, Asher M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)